International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Since Year 2012 | Open Access | Fully Refereed | Peer Reviewed

ISSN: 2319-7064




Downloads: 114

Research Paper | Medicine Science | India | Volume 4 Issue 6, June 2015


Efficacy and Safety Evaluation of Bresol Tablet in Allergic Rhinitis- A Double Blind Placebo Controlled Clinical Study

Dr. Mohan Jagade | Dr. Kavitha Rajarathna


Abstract: Allergic rhinitis (AR), often considered a trivial disease, is now increasingly being recognized as a cause of significant and widespread morbidity. It is the most common allergic disorder, affecting 10-20 percent of the population. Currently available therapeutic options in the management of AR have major limitations due to low clinical efficacy and associated adverse events. This study was planned to evaluate the clinical efficacy and safety (short- and long-term) of Bresol tablets in AR. The study was a placebo controlled, phase III clinical trial conducted as per the ethical guidelines of Declaration of Helsinki. One hundred subjects from the age group of 15 to 60 years who presented with symptoms of AR were included in the study. At the initial visit, a detailed medical history was obtained by interviewing the subjects, which was followed by thorough clinical examination and all the subjects were investigated by hematological and biochemical tests. Subjects were advised to consume one Bresol tablet, twice-daily for 4 weeks while subjects in placebo group received identical looking placebo in the same dose, for a period of 4 weeks. The predefined primary endpoints were proportion of subjects with rapid symptomatic control and clinical improvement, along with renormalization of laboratory parameters. The results were statistically analyzed by Mann Whitney test and Paired t test. The mean score sneezing, nasal congestion, itching of the eyes, itching of the nose, postnasal drip, rhinorrhea and watery eyes decreased significantly at the end of 4 weeks, when compared to the Placebo and respective baseline values. There was a significant reduction in the Total WBC Count, Neutrophils, Lymphocytes, Eosinophils, Monocytes, ESR and Absolute Eosinophil Count at the end of 4 weeks, when compared to the placebo group. There were no clinically significant adverse reactions, either reported or observed during the entire study period. The overall compliance to the treatment was good and no treatment discontinuations were reported. Therefore, it may be concluded that Bresol tablets are effective and safe in the management of AR.


Keywords: Bresol Tablet, Allergic Rhinitis, Clinical trial


Edition: Volume 4 Issue 6, June 2015,


Pages: 462 - 468

Efficacy and Safety Evaluation of Bresol Tablet in Allergic Rhinitis- A Double Blind Placebo Controlled Clinical Study


How to Cite this Article?

Dr. Mohan Jagade, Dr. Kavitha Rajarathna, "Efficacy and Safety Evaluation of Bresol Tablet in Allergic Rhinitis- A Double Blind Placebo Controlled Clinical Study", International Journal of Science and Research (IJSR), https://www.ijsr.net/get_abstract.php?paper_id=SUB153720, Volume 4 Issue 6, June 2015, 462 - 468, #ijsrnet

How to Share this Article?

Enter Your Email Address




Similar Articles with Keyword 'Allergic Rhinitis'

Downloads: 109

Research Paper, Medicine Science, India, Volume 8 Issue 9, September 2019

Pages: 686 - 688

Effect of Loratadine Tablets on the Symptomatic Control of Seasonal Allergic Rhinitis in Adults Challenged with Ragweed Pollen in the Environmental Exposure Unit in Compassion with Azelastine Nasal Spray with Loratadine Tablets, Cetirizine Tablets, and Placebo: A Post Hoc Analysis of Total Symptom Score

Dr. T. Sujatha

Share this Article

Downloads: 127

Research Paper, Medicine Science, India, Volume 4 Issue 1, January 2015

Pages: 1865 - 1868

Correlation of Peripheral Eosinophilia with Severity of Nasobronchial Allergy

Apar Jindal [2] | Subramanian.S [3] | Meenakshi.N [3] | Ragulan.R [2] | Viswambhar.V [2] | Arun Babu.V [2]

Share this Article


Top